Capromorelin

未知生产厂商

Capromorelin is under investigation in clinical trial NCT00527046 (Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Capromorelin is under investigation in clinical trial NCT00527046 (Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults).

技术标识符

化学式: C₂₈H₃₅N₅O₄
CAS 编号: 193273-66-4
UNII ID: 0MQ44VUN84

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COMPOSITIONS AND METHODS OF USE OF AN INAPPETANCE-CONTROLLING COMPOUND
EP 2906041 A4申请人: ARATANA THERAPEUTICS INC优先权: 2012
CN
EP
US
WO
8 件公开
Compositions and methods for chronic use of a weight-gaining compound
US 9700591 B2申请人: ARATANA THERAPEUTICS INC优先权: 2015
CN
US
4 件公开
Asymmetric synthetic method for Capromorelin chiral intermediate
CN 109320515 A申请人: UNIV CHANGZHOU优先权: 2018
CN

药物